Literature DB >> 7251860

Evidence for adenosine mediation of atrioventricular block in the ischemic canine myocardium.

L Belardinelli, E C Mattos, R M Berne.   

Abstract

Adenosine levels in oxygen-deprived myocardium can rise to 10- 100 microM concentrations known to cause atrioventricular (AV) conduction delay and block. We reported that the AV conduction delay and block caused by hypoxia is markedly attenuated by 10 microM aminophylline, and adenosine competitive antagonist. THe purpose of the present study was to investigate adenosine's role in ischemic AV conduction disturbances. Dogs were anesthetized and instrumented for His bundle and surface electrogram recordings. The total AV conduction time was subdivided in to atrial-His bundle (AH) and His bundle-ventricle intervals. The atrioventricular node artery (AVNA) was cannulated for selective injection of drugs in the AV node region. Adenosine (10 to 100 microgram), as a 2-ml bolus injection, rapidly produced a dose-dependent, transient increase in the AH interval; a 1,000-microgram dose caused second degree AV block. The duration of the increase in AH interval was also dose-dependent. Dipyridamole, and inhibitor of nucleoside transport, potentiated the negative dromotropic effects of adenosine, whereas aminophylline attenuated them. In some dogs, after cannulation of the AVNA, first and second degree AV block occurred spontaneously or were induced by rapid atrial pacing. Injection of the aminophylline (5 mg/kg, i.e.) or theophylline (100-1,000 microgram) into the AVNA rapidly reversed the AV blocks. Upon washout of the drugs the AV blocks recurred. We conclude that endogenously released adenosine may account for a major fraction of the AV conduction delay and block associated with impaired blood supply to the AV node, and the theophylline and aminophylline reverse the AV conduction defect by antagonizing the effects of adenosine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251860      PMCID: PMC370787          DOI: 10.1172/jci110235

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Adenosine as inhibitor of myocardial effects of catecholamines.

Authors:  J Schrader; G Baumann; E Gerlach
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

2.  Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog.

Authors:  D P Zipes; J C Fischer
Journal:  Circ Res       Date:  1974-02       Impact factor: 17.367

3.  Effect of nitroglycerin and dipyridamole on regional coronary resistance.

Authors:  W M Fam; M McGregor
Journal:  Circ Res       Date:  1968-05       Impact factor: 17.367

4.  Sensitivity changes in the dog heart to norepinephrine, calcium and aminophyline resulting from pretreatment with reserpine.

Authors:  D P Westfall; W W Fleming
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

5.  Effects of adenosine and ATP on AV conduction and on AV junctional rhythm.

Authors:  F Urthaler; T N James
Journal:  J Lab Clin Med       Date:  1972-01

6.  Cardiovascular response to increasing theophylline concentrations.

Authors:  R I Ogilvie; P G Fernandez; F Winsberg
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

7.  Effects of neurotransmitters injected into the posterior and the anterior septal artery on the automaticity of the atrioventricular junctional area of the dog heart.

Authors:  S Motomura; T Iijima; N Taira; K Hashimoto
Journal:  Circ Res       Date:  1975-08       Impact factor: 17.367

8.  Experimental studies on the pathogenesis of asystole after verapamil in the dog.

Authors:  F Urthaler; T N James
Journal:  Am J Cardiol       Date:  1979-10       Impact factor: 2.778

9.  Release of adenosine from human hearts during angina induced by rapid atrial pacing.

Authors:  A C Fox; G E Reed; E Glassman; A J Kaltman; B B Silk
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  Ca and Na selectivity of the active membrane of rabbit AV nodal cells.

Authors:  T Akiyama; H A Fozzard
Journal:  Am J Physiol       Date:  1979-01
View more
  15 in total

1.  Changes in adenosine receptors during differentiation of 3T3-F442A cells to adipocytes.

Authors:  K Ravid; J M Lowenstein
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

Review 2.  Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology.

Authors:  S Jamal Mustafa; R Ray Morrison; Bunyen Teng; Amir Pelleg
Journal:  Handb Exp Pharmacol       Date:  2009

Review 3.  Safety considerations in the use of drug combinations during general anaesthesia.

Authors:  E S Ransom; R A Mueller
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

Review 4.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

5.  Adenosine: an importance beyond ATP.

Authors:  A H Watt; P A Routledge
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

6.  [Cardiac effects of adenosine. Mechanism of action, pathophysiologic and clinical significance].

Authors:  M Böhm
Journal:  Klin Wochenschr       Date:  1987-06-01

7.  Antiadrenergic effects of adenosine on His-Purkinje automaticity. Evidence for accentuated antagonism.

Authors:  B B Lerman; R C Wesley; J P DiMarco; D E Haines; L Belardinelli
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 8.  Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients.

Authors:  Douglas L Jennings; Brandon Martinez; Sheila Montalvo; David E Lanfear
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

Review 9.  Controlled hypotension: a guide to drug choice.

Authors:  Christian-Serge Degoute
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Evidence against the adenosine-catecholamine antagonism under in vivo conditions.

Authors:  R Seitelberger; W Schütz; O Schlappack; G Raberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.